logo
SHOO Q1 Earnings Call: Tariffs Drive Strategy Shift, Kurt Geiger Acquisition Adds Growth Potential

SHOO Q1 Earnings Call: Tariffs Drive Strategy Shift, Kurt Geiger Acquisition Adds Growth Potential

Yahoo11-06-2025
Shoe and apparel company Steven Madden (NASDAQ:SHOO) missed Wall Street's revenue expectations in Q1 CY2025, with sales flat year on year at $553.5 million. Its non-GAAP profit of $0.60 per share was 31.7% above analysts' consensus estimates.
Is now the time to buy SHOO? Find out in our full research report (it's free).
Revenue: $553.5 million vs analyst estimates of $559.1 million (flat year on year, 1% miss)
Adjusted EPS: $0.60 vs analyst estimates of $0.46 (31.7% beat)
Adjusted EBITDA: $61.33 million vs analyst estimates of $49.57 million (11.1% margin, 23.7% beat)
Operating Margin: 9.7%, in line with the same quarter last year
Locations: 314 at quarter end, up from 253 in the same quarter last year
Market Capitalization: $1.8 billion
Steven Madden's first quarter performance was shaped by persistent headwinds in the footwear and accessories industry and the company's rapid response to shifting market dynamics. CEO Ed Rosenfeld highlighted that while sales trends were sluggish early in the quarter, demand improved markedly in March as seasonal product assortments resonated with consumers. The company credited its product and marketing teams for supporting demand through targeted campaigns, such as the "House of Steve" initiative. Rosenfeld also acknowledged heightened uncertainty from new U.S. tariffs on imports, noting, 'Our team moved swiftly to adapt to the changing landscape with a focus on mitigating near-term impacts while positioning the company for long-term growth.'
Looking ahead, management is focused on mitigating the impact of tariffs by accelerating supply chain shifts away from China, implementing selective price increases, and seeking operational efficiencies. Rosenfeld emphasized that while the company faces near-term challenges, it is leveraging its ability to pivot production and maintain supplier relationships to protect market share. The acquisition of Kurt Geiger is seen as a strategic addition, with Rosenfeld stating, 'We believe the agility of our business model, combined with our fortress balance sheet, gives us a competitive advantage in dynamic environments like this one.' However, the company withdrew its annual financial guidance due to ongoing uncertainty, underscoring the need for close monitoring of consumer demand and tariff developments.
Management attributed the quarter's performance to disciplined execution in product assortment, rapid supply chain adjustments, and early action in response to tariff impacts.
Seasonal product success: The launch of spring assortments was well received by consumers, especially as weather improved in March, helping reverse sluggish sales seen earlier in the quarter. Increased marketing investment, including the 'House of Steve' campaign, supported brand engagement.
Accelerated supply chain shift: In response to new tariffs, Steven Madden rapidly reduced its reliance on China for U.S. imports, moving much of its fall 2025 production to countries such as Vietnam, Cambodia, Mexico, and Brazil. Management noted that, by spring 2026, less than 10% of sourcing for U.S. imports (excluding Kurt Geiger) is expected to come from China.
Price increases and demand monitoring: The company has begun raising prices selectively across products and brands, with average increases around 10%. Management is closely monitoring demand elasticity to ensure competitiveness and will adjust pricing strategies as needed.
Inventory and logistics adjustments: Inventory levels rose, driven by longer lead times from supply chain diversification and efforts to accelerate shipments ahead of tariff implementation. Management stated this was a proactive measure to manage disruption and maintain product availability.
Kurt Geiger acquisition: The purchase of Kurt Geiger, a London-based accessories brand, was completed. The brand's momentum, especially in U.S. digital channels and international expansion, is expected to support long-term growth, though management acknowledged that 80% of its sourcing is currently from China, requiring a similar transition strategy.
Management expects future performance to be influenced by tariff-related cost pressures, supply chain transitions, and the integration of Kurt Geiger.
Tariff impact and mitigation: The company anticipates further gross margin pressure as tariffs on imports take full effect, particularly as it cycles through higher-cost inventory. Management is pursuing supplier negotiations, price increases, and operational efficiencies to offset these headwinds.
Kurt Geiger integration: Leveraging Kurt Geiger's digital and physical retail expansion in the U.S., as well as international growth opportunities, is a strategic priority. Management aims to align sourcing practices with Steven Madden's transition away from China to reduce future tariff exposure.
Consumer demand and promotional activity: There is uncertainty regarding consumer response to higher prices and later product deliveries caused by longer lead times. Management highlighted that direct-to-consumer performance was mixed in April and indicated a cautious outlook on consumer confidence, requiring ongoing assessment of trends and promotional needs.
In future quarters, the StockStory team will track (1) the pace at which Steven Madden reduces China-based sourcing across both legacy and Kurt Geiger brands, (2) the effect of price increases and shifting supply chains on gross margin and sales trends, and (3) execution on U.S. and international expansion plans, especially for Kurt Geiger. Progress on integrating Kurt Geiger's operations and adapting to ongoing tariff developments will also be key signposts.
Steven Madden currently trades at a forward P/E ratio of 13.5×. At this valuation, is it a buy or sell post earnings? See for yourself in our full research report (it's free).
Market indices reached historic highs following Donald Trump's presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth.
While this has caused many investors to adopt a "fearful" wait-and-see approach, we're leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Faruqi & Faruqi Reminds Iovance Biotherapeutics of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 14, 2025
Faruqi & Faruqi Reminds Iovance Biotherapeutics of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 14, 2025

Associated Press

time41 minutes ago

  • Associated Press

Faruqi & Faruqi Reminds Iovance Biotherapeutics of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 14, 2025

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Iovance To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Iovance between August 8, 2024 and May 8, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - July 4, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Iovance Biotherapeutics, Inc. ('Iovance' or the 'Company') (NASDAQ: IOVA) and reminds investors of the July 14, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. [ This image cannot be displayed. Please visit the source: ] Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose the true state of Iovance's growth potential; notably, that it was not equipped to generate and drive demand or was otherwise ill equipped to capitalize upon the purported existing demand for its treatments through its network of approved treatment centers. On July 25, 2024, Iovance announced its financial results for the second quarter of fiscal 2024 and reduced its revenue guidance for the full fiscal year 2024. The Company attributed its results and lowered guidance on 1) 'the iCTC completed annual scheduled maintenance in December' and 'capacity was reduced by more than half for about 1 month,' 2) "[l]ower Proleukin sales' than the company expected, and 3) 'the variable pace at which ATCs began treatment patients.' Investors and analysts reacted immediately to Iovance's revelation. The price of Iovance's common stock declined dramatically. From a closing market price of $3.17 per share on May 8, 2025, Iovance's stock price fell to $1.75 per share on May 9, 2025, a decline of about 44.795% in the span of just a single day. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding Iovance's conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the Iovance class action, go to or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Follow us for updates on LinkedIn, on X, or on Facebook. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner. To view the source version of this press release, please visit

Calculating The Intrinsic Value Of InterDigital, Inc. (NASDAQ:IDCC)
Calculating The Intrinsic Value Of InterDigital, Inc. (NASDAQ:IDCC)

Yahoo

timean hour ago

  • Yahoo

Calculating The Intrinsic Value Of InterDigital, Inc. (NASDAQ:IDCC)

InterDigital's estimated fair value is US$251 based on 2 Stage Free Cash Flow to Equity InterDigital's US$225 share price indicates it is trading at similar levels as its fair value estimate Analyst price target for IDCC is US$220 which is 12% below our fair value estimate Today we will run through one way of estimating the intrinsic value of InterDigital, Inc. (NASDAQ:IDCC) by taking the expected future cash flows and discounting them to their present value. Our analysis will employ the Discounted Cash Flow (DCF) model. Don't get put off by the jargon, the math behind it is actually quite straightforward. Companies can be valued in a lot of ways, so we would point out that a DCF is not perfect for every situation. If you still have some burning questions about this type of valuation, take a look at the Simply Wall St analysis model. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. We use what is known as a 2-stage model, which simply means we have two different periods of growth rates for the company's cash flows. Generally the first stage is higher growth, and the second stage is a lower growth phase. To begin with, we have to get estimates of the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years. A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, so we discount the value of these future cash flows to their estimated value in today's dollars: 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 Levered FCF ($, Millions) US$214.2m US$274.2m US$307.8m US$336.9m US$362.2m US$384.4m US$404.3m US$422.5m US$439.6m US$455.9m Growth Rate Estimate Source Analyst x3 Analyst x1 Est @ 12.26% Est @ 9.46% Est @ 7.51% Est @ 6.14% Est @ 5.18% Est @ 4.51% Est @ 4.04% Est @ 3.71% Present Value ($, Millions) Discounted @ 8.1% US$198 US$235 US$244 US$247 US$246 US$241 US$235 US$227 US$219 US$210 ("Est" = FCF growth rate estimated by Simply Wall St)Present Value of 10-year Cash Flow (PVCF) = US$2.3b We now need to calculate the Terminal Value, which accounts for all the future cash flows after this ten year period. For a number of reasons a very conservative growth rate is used that cannot exceed that of a country's GDP growth. In this case we have used the 5-year average of the 10-year government bond yield (2.9%) to estimate future growth. In the same way as with the 10-year 'growth' period, we discount future cash flows to today's value, using a cost of equity of 8.1%. Terminal Value (TV)= FCF2035 × (1 + g) ÷ (r – g) = US$456m× (1 + 2.9%) ÷ (8.1%– 2.9%) = US$9.2b Present Value of Terminal Value (PVTV)= TV / (1 + r)10= US$9.2b÷ ( 1 + 8.1%)10= US$4.2b The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is US$6.5b. In the final step we divide the equity value by the number of shares outstanding. Relative to the current share price of US$225, the company appears about fair value at a 11% discount to where the stock price trades currently. Valuations are imprecise instruments though, rather like a telescope - move a few degrees and end up in a different galaxy. Do keep this in mind. The calculation above is very dependent on two assumptions. The first is the discount rate and the other is the cash flows. Part of investing is coming up with your own evaluation of a company's future performance, so try the calculation yourself and check your own assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at InterDigital as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 8.1%, which is based on a levered beta of 1.184. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business. See our latest analysis for InterDigital Strength Earnings growth over the past year exceeded the industry. Debt is not viewed as a risk. Dividends are covered by earnings and cash flows. Weakness Dividend is low compared to the top 25% of dividend payers in the Software market. Opportunity Good value based on P/E ratio and estimated fair value. Threat Annual earnings are forecast to decline for the next 3 years. Valuation is only one side of the coin in terms of building your investment thesis, and it is only one of many factors that you need to assess for a company. The DCF model is not a perfect stock valuation tool. Rather it should be seen as a guide to "what assumptions need to be true for this stock to be under/overvalued?" If a company grows at a different rate, or if its cost of equity or risk free rate changes sharply, the output can look very different. For InterDigital, we've compiled three fundamental aspects you should further research: Risks: For instance, we've identified 2 warning signs for InterDigital that you should be aware of. Future Earnings: How does IDCC's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart. Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing! PS. Simply Wall St updates its DCF calculation for every American stock every day, so if you want to find the intrinsic value of any other stock just search here. — Investing narratives with Fair Values Suncorp's Next Chapter: Insurance-Only and Ready to Grow By Robbo – Community Contributor Fair Value Estimated: A$22.83 · 0.1% Overvalued Thyssenkrupp Nucera Will Achieve Double-Digit Profits by 2030 Boosted by Hydrogen Growth By Chris1 – Community Contributor Fair Value Estimated: €14.40 · 0.3% Overvalued Tesla's Nvidia Moment – The AI & Robotics Inflection Point By BlackGoat – Community Contributor Fair Value Estimated: $359.72 · 0.1% Overvalued View more featured narratives — Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Xerox Holdings (NASDAQ:XRX) shareholders have endured a 47% loss from investing in the stock five years ago
Xerox Holdings (NASDAQ:XRX) shareholders have endured a 47% loss from investing in the stock five years ago

Yahoo

timean hour ago

  • Yahoo

Xerox Holdings (NASDAQ:XRX) shareholders have endured a 47% loss from investing in the stock five years ago

It is a pleasure to report that the Xerox Holdings Corporation (NASDAQ:XRX) is up 43% in the last quarter. But over the last half decade, the stock has not performed well. After all, the share price is down 61% in that time, significantly under-performing the market. Since shareholders are down over the longer term, lets look at the underlying fundamentals over the that time and see if they've been consistent with returns. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. Given that Xerox Holdings didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. That's because it's hard to be confident a company will be sustainable if revenue growth is negligible, and it never makes a profit. In the last five years Xerox Holdings saw its revenue shrink by 4.2% per year. That's not what investors generally want to see. The share price decline of 10% compound, over five years, is understandable given the company is losing money, and revenue is moving in the wrong direction. We don't think anyone is rushing to buy this stock. Ultimately, it may be worth watching - should revenue pick up, the share price might follow. The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image). It's probably worth noting we've seen significant insider buying in the last quarter, which we consider a positive. On the other hand, we think the revenue and earnings trends are much more meaningful measures of the business. You can see what analysts are predicting for Xerox Holdings in this interactive graph of future profit estimates. It is important to consider the total shareholder return, as well as the share price return, for any given stock. The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. In the case of Xerox Holdings, it has a TSR of -47% for the last 5 years. That exceeds its share price return that we previously mentioned. The dividends paid by the company have thusly boosted the total shareholder return. Xerox Holdings shareholders are down 47% for the year (even including dividends), but the market itself is up 16%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 8% over the last half decade. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. It's always interesting to track share price performance over the longer term. But to understand Xerox Holdings better, we need to consider many other factors. Take risks, for example - Xerox Holdings has 2 warning signs (and 1 which is concerning) we think you should know about. Xerox Holdings is not the only stock that insiders are buying. For those who like to find lesser know companies this free list of growing companies with recent insider purchasing, could be just the ticket. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store